Expand KRYS Menu
KRYS MENU

Krystal Biotech (KRYS) closed at $315.82 on November 19, 2026, up 0.2% from the previous close, on volume of 285,207 shares (30-day average 280,450).

Key numbers
  • Last close: $315.82 (November 19, 2026)
  • 52-week range: $203.18 to $382.54
  • Market value: $9.2 billion
  • 30-day implied volatility (IV30): 37.4%
  • Option volume: 153 contracts (38 calls, 115 puts); 30-day average 180

Data as of November 19, 2026.

KRYS Stock Summary and Trading Ideas (Krystal Biotech | NASDAQ:KRYS)

Charts for Today's Stock Price and Implied Volatility in Krystal Biotech

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for KRYS by Theoretical Edge and Win Rates

Sentiment

Largest Multi-Leg Option Trades (30 Days)

#DateStrategyLegsContracts
1 Nov 16, 2026 Diagonal Call Spread 20-Nov : 18-Dec-26340 : 320 C 1,000

Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 18, 2026. See the largest for 5, 30, 60 and 90 days

Trading Statistics

Key Ratios

Krystal Biotech (KRYS) Frequently Asked Questions

What does Krystal Biotech do?

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

What symbol and exchange does Krystal Biotech shares trade?

Krystal Biotech trades on the NASDAQ stock market under the symbol KRYS.

What is Krystal Biotech stock price doing today?

As of November 19, 2026, KRYS stock price climbed to $315.82 with 285,207 million shares trading.

What is Krystal Biotech's Beta?

KRYS has a beta of 0.91, meaning it tends to be less sensitive to market movements. KRYS has a correlation of 0.11 to the broad based SPY ETF.

How much is Krystal Biotech worth?

KRYS has a market cap of $9.23 billion. This is considered a Mid Cap stock.

How much money does Krystal Biotech make?

Last quarter Krystal Biotech reported $127 million in Revenue and $2.05 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.15.

What is the highest and lowest price Krystal Biotech traded in the last 3 year period?

In the last 3 years, KRYS traded as high as $382.54 and as low as $99.00.

What are the top ETFs holding Krystal Biotech?

The top ETF exchange traded funds that KRYS belongs to (by Net Assets): IJH, VTI, IWM, VB, XBI.

Is Krystal Biotech (KRYS) a good investment?

KRYS has outperformed the market in the last year with a price return of +54.3% while the SPY ETF gained +9.6%. KRYS has also outperformed the stock market ETF in the last 3 month and 2 week periods returning -5.1% and +1.6%, respectively, while the SPY returned -6.5% and -6.6%, respectively.

What are the support and resistance levels for Krystal Biotech (KRYS)?

KRYS support price is $308.12 and resistance is $322.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KRYS shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes